372PDFirst-in-human (FIH) study of TAS-120, a highly...

Annals of Oncology 2017 / 09 Vol. 28; Iss. suppl_5

372PDFirst-in-human (FIH) study of TAS-120, a highly selective covalent oral fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced solid tumors

Kuboki, Y., Matsubara, N., Bando, H., Shitara, K., Yoh, K., Kojima, T., Ohno, I., Takahashi, H., Harano, K., Kondo, S., Hirai, H., Morizane, C., Doi, T.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx367.006
Date:
September, 2017
File:
PDF, 50 KB
english, 2017
Conversion to is in progress
Conversion to is failed